title: [The relationship between metabolic control and the plasma total homocysteine in type 2 diabetes treated with insulin].
abstract: OBJECTIVE
  To study the relationship between metabolic control and the plasma total homocysteine (tHcy) in type 2 diabetes treated with insulin.
  
  
  METHODS
  A total of 68 patients with type 2 diabetes were recruited. At baseline and the end of 3 month therapy, fasting blood samples were collected for measuring fasting blood glucose (FBG), HbA1c, tHcy and other routine biochemical testing and postprandial blood was collected to measure postprandial blood glucose (PBG).
  
  
  RESULTS
  FBG, PBG and HbA1c decreased significantly (P < 0.01) after 3 month intensive insulin therapy. tHcy also decreased, but the decrease did not reach statistic significance (P > 0.05). 7.0% of HbA1c was selected as the cut point judging the level of metabolic control. The HbA1c level was less than 7.0% in 31 (45.6%) patients after insulin treatment alone. In these patients, FBG, PBG and HbA1c significantly decreased, when compared with those of pre-treatment. The plasma tHcy decreased significantly as well.
  
  
  CONCLUSIONS
  After insulin treatment, the plasma tHcy decreases when the metabolic control is improved significantly.
authors.affiliation: Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China.
authors.forename: Guo-qing
authors.initials: GQ
authors.lastname: Yang
authors.forename: Ju-ming
authors.initials: JM
authors.lastname: Lu
authors.forename: Hua
authors.initials: H
authors.lastname: Zheng
authors.forename: Fang-ling
authors.initials: FL
authors.lastname: Ma
authors.forename: Xiao-man
authors.initials: XM
authors.lastname: Zou
authors.forename: Chang-yu
authors.initials: CY
authors.lastname: Pan
mesh_terms: D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D006710:Homocysteine; D007004:Hypoglycemic Agents; D007328:Insulin